A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Chinese PLA General Hospital
Ossium Health, Inc.
City of Hope Medical Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Chinese PLA General Hospital
Thomas Jefferson University
Baptist Health South Florida
M.D. Anderson Cancer Center
Arog Pharmaceuticals, Inc.
Columbia University
M.D. Anderson Cancer Center
Washington University School of Medicine
Arog Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Children's Oncology Group
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
German CLL Study Group
UNC Lineberger Comprehensive Cancer Center